products

Alecensa® (alectinib)

Alecensa® (alectinib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

Avastin® (bevacizumab)

Avastin® (bevacizumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Bondronat® (ibandronic acid)

Bondronat® (ibandronic acid)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Cotellic® (cobimetinib)

Cotellic® (cobimetinib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI

 

Erivedge® (vismodegib)

Erivedge® (vismodegib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheets (SDS)

 

Gazyva® (obinutuzumab)

Gazyva® (obinutuzumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Herceptin® (trastuzumab) powder for IV infusion

Herceptin® (trastuzumab) powder for IV infusion

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Herceptin® SC (trastuzumab) solution for SC injection

Herceptin® SC (trastuzumab) solution for SC injection

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Kadcyla® (trastuzumab emtansine)

Kadcyla® (trastuzumab emtansine)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

Kytril® (granisetron)

Kytril® (granisetron)

In July 2017, Roche transferred the sponsorship and responsibility for sales and marketing of Kytril (granisetron) to Atnahs Pty Limited within Australia.

The current Consumer Medicine Information (CMI) and Product Information (PI) for Kytril are available from the Therapeutic Goods Administration (TGA) website at: http://www.tga.gov.au/about/ebs-picmi.htm.

MabThera® (rituximab) solution for IV infusion (for NHL and CLL)

MabThera® (rituximab) solution for IV infusion (for NHL and CLL)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

MabThera® SC (rituximab) solution for SC injection (for NHL and CLL)

MabThera® SC (rituximab) solution for SC injection (for NHL and CLL)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Perjeta® (pertuzumab)

Perjeta® (pertuzumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Tarceva® (erlotinib)

Tarceva® (erlotinib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Tecentriq® (atezolizumab)

Tecentriq® (atezolizumab)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet

Xeloda® (capecitabine)

Xeloda® (capecitabine)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)

 

Zelboraf® (vemurafenib)

Zelboraf® (vemurafenib)

Patients

Consumer Medicine Information (CMI)

Healthcare Professionals
Product Information (PI) | Safety Data Sheet (SDS)